Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 3
1975 1
1985 2
1986 2
1990 1
1991 3
1992 1
1993 2
1994 1
1995 1
1996 3
1997 3
1998 2
1999 5
2000 2
2001 6
2002 8
2003 9
2004 9
2005 8
2006 9
2007 10
2008 16
2009 10
2010 19
2011 19
2012 29
2013 19
2014 32
2015 25
2016 38
2017 36
2018 27
2019 20
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

346 results
Results by year
Filters applied: . Clear all
Page 1
Long non-coding RNAs in anti-cancer drug resistance.
Chen QN, Wei CC, Wang ZX, Sun M. Chen QN, et al. Among authors: Wei CC. Oncotarget. 2017 Jan 3;8(1):1925-1936. doi: 10.18632/oncotarget.12461. Oncotarget. 2017. PMID: 27713133 Free PMC article. Review.
Allergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression.
Wei CC, Kung YJ, Chen CS, Chang CY, Lin CJ, Tien PT, Chang HY, Chen HJ, Huang YS, Lin HJ, Wan L. Wei CC, et al. EBioMedicine. 2018 Feb;28:274-286. doi: 10.1016/j.ebiom.2018.01.024. Epub 2018 Jan 31. EBioMedicine. 2018. PMID: 29398596 Free PMC article.
Acute pulmonary effects of aerosolized nicotine.
Ahmad S, Zafar I, Mariappan N, Husain M, Wei CC, Vetal N, Eltoum IA, Ahmad A. Ahmad S, et al. Among authors: Wei CC. Am J Physiol Lung Cell Mol Physiol. 2019 Jan 1;316(1):L94-L104. doi: 10.1152/ajplung.00564.2017. Epub 2018 Oct 25. Am J Physiol Lung Cell Mol Physiol. 2019. PMID: 30358437 Free PMC article.
PM2.5 and NOx exposure promote myopia: clinical evidence and experimental proof.
Wei CC, Lin HJ, Lim YP, Chen CS, Chang CY, Lin CJ, Chen JJ, Tien PT, Lin CL, Wan L. Wei CC, et al. Environ Pollut. 2019 Nov;254(Pt B):113031. doi: 10.1016/j.envpol.2019.113031. Epub 2019 Aug 15. Environ Pollut. 2019. PMID: 31454569
Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks.
Kavanaugh A, Marzo-Ortega H, Vender R, Wei CC, Birt J, Adams DH, Benichou O, Lin CY, Nash P. Kavanaugh A, et al. Among authors: Wei CC. Clin Exp Rheumatol. 2019 Jul-Aug;37(4):566-574. Epub 2018 Nov 19. Clin Exp Rheumatol. 2019. PMID: 30557128 Free article. Clinical Trial.
346 results
Jump to page
Feedback